Document Detail

New guideline sets the ground rules for routine molecular testing in non-small cell lung cancer.
MedLine Citation:
PMID:  23791446     Owner:  NLM     Status:  In-Data-Review    
The guest editorial highlights the new guidelines for selecting lung cancer patients for EGFR and ALK tyrosine kinase ihibitor molecular testing.
Nathan A Pennell; Raymond R Tubbs
Related Documents :
24272356 - Hypoxic vdac1: a potential mitochondrial marker for cancer therapy.
23720056 - Tr3 modulates platinum resistance in ovarian cancer.
24198636 - Sipuleucel-t: immunotherapy for advanced prostate cancer.
23893766 - Regulation of cellular processes by interleukin-16 in homeostasis and cancer.
20600216 - Individual differences in arsenic metabolism and lung cancer in a case-control study in...
3345886 - Colorectal cancer in patients with ulcerative colitis. a population study in central is...
Publication Detail:
Type:  Editorial    
Journal Detail:
Title:  The Journal of molecular diagnostics : JMD     Volume:  15     ISSN:  1943-7811     ISO Abbreviation:  J Mol Diagn     Publication Date:  2013 Jul 
Date Detail:
Created Date:  2013-06-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100893612     Medline TA:  J Mol Diagn     Country:  United States    
Other Details:
Languages:  eng     Pagination:  413-4     Citation Subset:  IM    
Copyright Information:
Copyright © 2013 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
Department of Solid Tumor Oncology, Taussig Cancer Institute, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Epidemiological analysis of maxillofacial fractures treated at a university hospital, Xinjiang, Chin...
Next Document:  The challenges of comparing a clinically validated test to other methods.